Navigation Links
MDS Analytical Technologies Acquires Blueshift Biotechnologies

Complementary technology to augment MDS Analytical Technologies' cellular

analysis capabilities

SUNNYVALE, CA, June 27 /PRNewswire-FirstCall/ - MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences research, today announced it has acquired California-based Blueshift Biotechnologies (Sunnyvale, CA) for $13 million. The acquisition of Blueshift Biotechnologies, a developer of screening platforms for life sciences research and maker of the IsoCyte(TM) benchtop laser scanning cytometer, expands MDS Analytical Technologies' capabilities in cellular analysis, and further strengthens the company's global sales and service offering.

High Content Screening (HCS) and High Content Analysis (HCA) are growing trends in both pharmaceutical drug screening and life sciences research. MDS Analytical Technologies' cellular imaging product line now includes imaging systems and software that provide life sciences and drug discovery researchers with a more complete solution to conduct HCS and HCA. Cellular imaging provides intracellular information on compound effects for a large variety of cellular processes. Blueshift Biotechnologies' IsoCyte(TM) instrument conducts rapid image analysis of large populations of cells in a microtiter plate whole-well format. Whole-well, rapid cellular analysis enables a cost-effective solution for the adoption of HCS and HCA into high throughput screening environments.

"This acquisition fills a gap in our current product portfolio, allowing us to offer our pharmaceutical research customers fast and simple cellular analysis with a line of instrumentation that images the whole well at true high throughput screening rates," said Andy Boorn, president of MDS Analytical Technologies. "There are currently fourteen IsoCyte instruments installed at academic, biotech and pharmaceutical companies in North America. With our extensive global sales force, we have the ability to bring this novel product to a wider global market."

"We are very excited about this opportunity for Blueshift Biotechnologies to merge into a world-class company like MDS Analytical Technologies," stated Evan Cromwell, president of Blueshift Biotechnologies. "The breadth and strength of its sales and marketing efforts mean that we will be able to increase awareness of this unique high-throughput imaging tool in new markets."

About MDS Analytical Technologies

MDS Analytical Technologies is a newly established MDS Inc. business unit and is a world-class organization comprised of two main lines of business. The Sciex product portfolio offers proven market leadership in mass spectrometry through its joint ventures with two of the world's leading analytical instrumentation and life sciences companies, Applied Biosystems, a business of Applera Corporation, and PerkinElmer Inc. Molecular Devices' product portfolio is the gold standard in high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Find out more at or

About MDS Inc.

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS, Inc. has more than 5,500 highly skilled people in 29 countries. Find out more at or by calling 1-888-MDS-7222, 24 hours a day.

SOURCE MDS Analytical Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pace Analytical Services, Inc., Purchases Laucks Testing Laboratory, Inc.
2. Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
3. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
4. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
5. CRC Technologies Partners with Intronis, Giving Dental Communities Something to Smile About
6. RF Technologies(R) Introduces Enhanced Clinical Support Service, Step-by-Step, a Comprehensive Program Designed to Ensure Infant Security
7. Legislation Brings Hope for People With Disabilities Left Out of New Communications Technologies
8. Global Med Technologies(R), Inc. Secures $6 Million Credit Facility From Silicon Valley Bank for Inlog Acquisition
9. Dilon Technologies Announces National Agreement with MedAssets
10. VNUS Medical Technologies to Present at William Blair & Companys 28th Annual Growth Stock Conference
11. DICOM Services Grid(TM) From Acuo Technologies(R) Available Through EMC Select
Post Your Comments:
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary ... Periwinkle Pioneers, nominated by the public, will receive special recognition throughout 2016 as ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 --> ... devices was valued at $11,171.1 million in 2014, and ... 5.7% during 2015 - 2022. The global market is ... of diabetes. In addition, the increase in obese population ... to the growth of the market. Furthermore, technological advancements ...
Breaking Medicine Technology: